Literature DB >> 15655144

Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.

Marga Lammert1, Jan M Friedman, Lan Kluwe, Victor F Mautner.   

Abstract

OBJECTIVE: To determine the prevalence of neurofibromatosis 1 (NF1) among 6-year-old children in Germany. SETTING AND PATIENTS: A total of 152819 children aged 6 years in 6 German states were screened for NF1 during routine medical examinations at elementary school enrollment in cooperation with local health departments in 2000 and 2001. MAIN OUTCOME MEASURE: The prevalence of NF1 among 6-year-old German children was estimated to be 1:2996 (95% confidence interval, 1:2260 to 1:3984).
RESULTS: Fifty-one NF1 cases were identified and confirmed by evaluation by appropriate medical specialists. Seven other children were found to have multiple cafe au lait spots without other apparent features of NF1. A minimum estimate of the crude prevalence was 3.0 per 10 000 (95% confidence interval, 2.3-4.0 per 10 000 population). The incidence of NF1 in this population was probably in the range of 30 to 38 cases per 100 000 live births.
CONCLUSION: Our study obtained a nearly unbiased birth incidence of NF1 of approximately 1 in 2600 to 1 in 3000 and demonstrates that NF1 can be diagnosed by age 6 years in most cases by routine physical examination with special attention to the disease-associated skin stigmata.

Entities:  

Mesh:

Year:  2005        PMID: 15655144     DOI: 10.1001/archderm.141.1.71

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  93 in total

1.  Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Authors:  Luca Ferrari; Giulietta Scuvera; Arianna Tucci; Donatella Bianchessi; Francesco Rusconi; Francesca Menni; Elena Battaglioli; Donatella Milani; Paola Riva
Journal:  Hum Genet       Date:  2017-08-03       Impact factor: 4.132

Review 2.  The NF1 somatic mutational landscape in sporadic human cancers.

Authors:  Charlotte Philpott; Hannah Tovell; Ian M Frayling; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2017-06-21       Impact factor: 4.639

3.  MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.

Authors:  V F Mautner; M Hartmann; L Kluwe; R E Friedrich; C Fünsterer
Journal:  Neuroradiology       Date:  2006-01-24       Impact factor: 2.804

4.  RASopathies are associated with a distinct personality profile.

Authors:  Varoona Bizaoui; Jessica Gage; Rita Brar; Katherine A Rauen; Lauren A Weiss
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-16       Impact factor: 3.568

5.  Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.

Authors:  Peter Matthew Kennedy de Blank; Jeffrey Ira Berman; Grant T Liu; Timothy Paul Leslie Roberts; Michael Jay Fisher
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

6.  fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies.

Authors:  P de Blank; K Cole; L Kersun; A Green; J J Wilkes; J Belasco; R Bagatell; L C Bailey; M J Fisher
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

7.  Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Caglayan T Tuzcu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma.

Authors:  A Azad; G Chong; A Tauro; A Aly; N C Tebbutt
Journal:  Med Oncol       Date:  2009-03-19       Impact factor: 3.064

Review 9.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

10.  Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

Authors:  Marike L D Broekman; Roelof Risselada; Jooyeon Engelen-Lee; Wim G M Spliet; Bon H Verweij
Journal:  Case Rep Med       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.